Inventaire - your friends and communities are your best library - Inventaire

Advances in the treatment of breast cancer

published in: Clinical Pharmacology & Therapeutics

date of publication: 2007-12-19

language: English

main subject: breast cancer

Cites articles 40

Date

Title

Authors

2007-05-01

Neoadjuvant use of endocrine therapy in breast cancer
2007-10-01

Neoadjuvant chemotherapy for operable breast cancer.
2007-07-01

Nab-paclitaxel for breast cancer: a new formulation with an improved safety profile and greater efficacy
2007-03-01

Targeting the microtubules in breast cancer beyond taxanes: the epothilones

Josep Baselga
2007-01-12

Progress and new standards of care in the management of HER-2 positive breast cancer

Chantal Bernard-Marty
2007-08-17

Angiogenesis as targeted breast cancer therapy

Kathy D. Miller, George Sledge
2007-07-01

Phase 2 randomized trial of primary endocrine therapy versus chemotherapy in postmenopausal patients with estrogen receptor-positive breast cancer

Garik A Dashyan
2007-09-04

Randomized active-controlled phase II study of denosumab efficacy and safety in patients with breast cancer-related bone metastases

Rossana Berardi
2006-06-21

Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial,Effects of Tamoxifen vs Raloxifene on the Risk of Developing Invasive Breast Cancer and Other Disease OutcomesThe NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 Trial

Reena Cecchini, Steven E. Reis, V. Craig Jordan, Patricia Ganz
2006-01-01

Capecitabine: expanding options for the treatment of patients with early or locally advanced breast cancer

Andrew M. Wardley
2006-02-01

Adjuvant docetaxel or vinorelbine with or without trastuzumab for breast cancer

Vesa Kataja, Taina Turpeenniemi-Hujanen, Akseli Hemminki
2006-12-28

Lapatinib plus capecitabine for HER2-positive advanced breast cancer

Arlene Chan, Cristina Oliva, Tadeusz Pieńkowski, Agnieszka Jagiello-Gruszfeld, Dimosthenis Skarlos
2006

Cancer statistics, 2006
2006-05-01

Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial

Lesley Fallowfield, Lester Barr
2006-06-01

Benefit of taxanes as adjuvant chemotherapy for early breast cancer: pooled analysis of 15,500 patients

Emilio Bria, Diana Giannarelli
2006-06-12

Targeted inhibition of farnesyltransferase in locally advanced breast cancer: a phase I and II trial of tipifarnib plus dose-dense doxorubicin and cyclophosphamide

Dawn L Hershman, Linda T Vahdat
2005-10-01

Effect of screening and adjuvant therapy on mortality from breast cancer

J. Dik F. Habbema
2005-12

Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials

Vaughan M. Evans, Michelino De Laurentiis
2005-07-01

Fulvestrant versus anastrozole for the treatment of advanced breast carcinoma: a prospectively planned combined survival analysis of two multicenter trials.

Anthony Howell, Ignace Vergote
2005-10-01

Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer

Sandra M. Swain, Greg Yothers, Daniel W Visscher, Edith A. Perez, Vera J Suman, Wilma L Lingle, James N Ingle, Eleftherios P Mamounas
2005-10-20

Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer.

Michael Untch, Martine Piccart-Gebhart, Josep Baselga, Luca Gianni, Mitch Dowsett, Hiroji Iwata
2005-08-10

Phase I safety, pharmacokinetics, and clinical activity study of lapatinib (GW572016), a reversible dual inhibitor of epidermal growth factor receptor tyrosine kinases, in heavily pretreated patients with metastatic carcinomas

E Claire Dees
2005-03-31

Bisphosphonates in breast cancer.
2005-06-13

Phase II study of temsirolimus (CCI-779), a novel inhibitor of mTOR, in heavily pretreated patients with locally advanced or metastatic breast cancer

Wolfgang Eiermann, Steve Chan, Fátima Cardoso, Vladimir Semiglazov
2005-05

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

Vaughan M. Evans, Michelino De Laurentiis
2005-11-01

Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study

Reena Cecchini
2005-11-01

Assessment of cardiac dysfunction in a randomized trial comparing doxorubicin and cyclophosphamide followed by paclitaxel, with or without trastuzumab as adjuvant therapy in node-positive, human epidermal growth factor receptor 2-overexpressing breast cancer: NSABP B-31

Greg Yothers, Sandra M. Swain, Eleftherios P Mamounas
2004-12-01

Cardiac safety of liposomal anthracyclines
2003-01-01

Advances in endocrine treatments for postmenopausal women with metastatic and early breast cancer
2003-02-01

Phase III trial of doxorubicin, paclitaxel, and the combination of doxorubicin and paclitaxel as front-line chemotherapy for metastatic breast cancer: an intergroup trial (E1193).

George Sledge, James N Ingle
2003-10

A phase I/II dose-escalation trial of bevacizumab in previously treated metastatic breast cancer

Kathy D. Miller, George Sledge
2003-07-01

Phase II study of the efficacy and tolerability of two dosing regimens of the farnesyl transferase inhibitor, R115777, in advanced breast cancer

Mitch Dowsett

Article - wd:Q37037373

Welcome to Inventaire

the library of your friends and communities

you are offline